Frontier Biotech (688221.SH) reported first-half results with a net loss of 160 million yuan

Zhitongcaijing · 08/30 15:33

Zhitong Finance App News, Frontier Biology (688221.SH) released its 2024 semi-annual report. During the reporting period, the company achieved operating income of 510.56 million yuan, an increase of 20.30% over the previous year; net loss attributable to shareholders of listed companies of 160 million yuan; net loss attributable to shareholders of listed companies deducted 176 million yuan in non-recurring profit and loss; and a basic loss of 0.43 yuan/share per share.